SCHEMBL4684173

SCHEMBL4684173

O=C1CCCc2nc(-c3nc(-c4ccccc4)c(F)n3-c3ccccc3)ccc21

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.42
GRM5 P41594 1/20 0.42
HPGD P15428 4/20 0.41
KDM4E B2RXH2 3/20 0.41
MAPT P10636 2/20 0.41
USP2 O75604 1/20 0.41
ALDH1A1 P00352 5/20 0.39
KMT2A Q03164 4/20 0.39
MEN1 O00255 2/20 0.39
HSD17B10 Q99714 1/20 0.39
HTT P42858 3/20 0.39
NPSR1 Q6W5P4 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
TSHR P16473 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.34
ELANE P08246 1/20 0.34
MAPK10 P53779 1/20 0.34
BCHE P06276 1/20 0.33
ACHE P22303 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4684508 0.87 ALDH1A1 (0.42) LMNAGRM5HPGDKDM4EMAPT
SCHEMBL4682517 0.87 LMNA (0.42) LMNAGRM5HPGDKDM4EMAPT
SCHEMBL4679352 0.82 GRM5 (0.46) GRM5ALDH1A1TSHRBCHEACHE
SCHEMBL4683095 0.82 CYP2C19 (0.46) LMNAHPGDKDM4EMAPTALDH1A1
SCHEMBL6103711 0.76 GRM5 (0.41) GRM5USP2HSD17B10TSHRACHE
SCHEMBL5039087 0.76 GRM5 (0.57) LMNAGRM5HPGDKDM4EMAPT
SCHEMBL30558432 0.76 GRM5 (0.57) LMNAGRM5HPGDKDM4EMAPT
SCHEMBL4680781 0.76 HPGD (0.51) LMNAGRM5HPGDKDM4EMAPT
SCHEMBL4787556 0.76 GRM5 (0.44) LMNAGRM5HPGDKDM4EMAPT
SCHEMBL4683600 0.76 GRM5 (0.40) GRM5KDM4EMAPTALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1943247-A1 TETRAHYDROQUINOLINONES AND THEIR USE AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS Merz Pharma GmbH & Co.KGaA (DE) 2008-07-16 EP claimed
WO-2007023245-A1 TETRAHYDROQUINOLINONES AND THEIR USE AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS MERZ PHARMA GMBH & CO. KGAA (DE) 2007-03-01 WO claimed
US-20060004001-A1 Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors MERZ PHARMA GMBH & CO., KGAA (DE) 2006-01-05 US claimed
EP-1943247-A1 TETRAHYDROQUINOLINONES AND THEIR USE AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS Merz Pharma GmbH & Co.KGaA (DE) 2008-07-16 EP disclosed
WO-2007023245-A1 TETRAHYDROQUINOLINONES AND THEIR USE AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS MERZ PHARMA GMBH & CO. KGAA (DE) 2007-03-01 WO disclosed
WO-2007023245-A1 TETRAHYDROQUINOLINONES AND THEIR USE AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS MERZ PHARMA GMBH & CO. KGAA (DE) 2007-03-01 WO disclosed
US-20060004001-A1 Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors MERZ PHARMA GMBH & CO., KGAA (DE) 2006-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060004001-A1 Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors GRM1, GRM5, GRM2 LMNA 4711/4885GRM5 2/4885HPGD 775/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.